48 results
PRE 14A
ONCR
Oncorus, Inc.
12 Jun 23
Preliminary proxy
6:33am
have evaluated and considered a variety of financial and strategic opportunities for the Company as part of our long-term strategy to enhance value … Advisors LLC(4)
Entities and persons affiliated with Citadel Multi-Strategy Equities Master Fund Ltd.(5)
K2 HealthVentures Equity Trust LLC and affiliates
8-K
EX-99.1
wm75m9jdz sq
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
j0k0r0frt 27we
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
8-K
EX-99.1
r5v7ui9cdmssw5shv
10 Jan 22
Regulation FD Disclosure
8:17am
424B5
5iqyju3q
19 Nov 21
Prospectus supplement for primary offering
4:41pm
S-3
tn9i4s04vaqzz r1i4
3 Nov 21
Shelf registration
5:00pm
8-K
EX-99.1
sfnyhiu1twixo0xi6cr
3 Nov 21
Oncorus Reports Third Quarter 2021 Financial Results and Provides Business Updates
7:18am
8-K
EX-99.1
ls3ff9qu
4 Aug 21
Oncorus Reports Second Quarter 2021 Financial Results and Provides Business Highlights
7:09am